1. Angell, M. 1985. Cost containment and the physician. JAMA 254(9): 1203–1207.
2. Barnbaum, D. 2011. You get what someone else will pay for. Theory and Application Ethics 1(2): 28–31.
3. Batt, S. 2000. The new genetic therapies: The case of Herceptin for breast cancer. In The gender of genetic futures: the Canadian biotechnology strategy, women and health, ed. F. Miller, L. Weir, R. Mykitiuk, P. Lee, S. Sherwin, and S. Tudiver, 9–17. Toronto: National Network on Environments and Women’s Health Working Paper Series.
4. Baylis, F., and J.S. Robert. 2006. Human embryonic stem cell research: An argument for national research review. Accountability in Research 13(3): 207–224.
5. Berg, J.W., M.J. Mehlman, D.B. Rubin, and E. Kodish. 2009. Making all the children above average: Ethical and regulatory concerns for pediatricians in pediatric enhancement research. Clinical Pediatrics 48(5): 472–480.